vaccine against HPV 16 and 18 is now being offered to pre-teenage boys and girls in the USA and continental Europe (see Chapter 9) in the belief that preventing infection with the two most oncogenic HPVs will have a dramatic effect on the incidence of cancer of the cervix in years to come.
